EndoGene.Bio

Turning menstrual blood into better drugs for endometriosis.

Why it ranks

2signal of 100 · rising 1

A sum of public facts, not a judgement and not investment advice.

Companies next to EndoGene.Bio
Company	Category	Status	Program
QvinShared: menstrual bloodYC W16ActiveAI	AI	Active	YCW16
DiamensShared: endometriosis, menstrualMassChallenge Switzerland 2025Not statedOther	Other	Not stated	MassChallengeSwitzerland 2025
Crane BiosciencesShared: biotechnology, healthcare, bloodEF 2022Not statedOther	Other	Not stated	EF2022
OminiShared: healthcare, bloodEF 2019Not statedOther	Other	Not stated	EF2019
DeeplifeShared: biotechnology, drugEF 2019Not statedOther	Other	Not stated	EF2019

Company	Category	Status
ExogeneAI for T-cell receptor discovery in oncology.Not statedAI	AI	Not stated
Nostos GenomicsAI variant interpretation for genetic diagnostics.Not statedAI	AI	Not stated
Bluevia HealthAI to prevent post-surgical complications.Not statedAI	AI	Not stated
DelfaAI agents for clinical trial management.Not statedAI	AI	Not stated
Lavender HealthBuilding the AI workforce for dental clinics.Not statedAI	AI	Not stated
LucentiaAI-powered cardiac diagnostics.Not statedAI	AI	Not stated

Programs EndoGene.Bio went through
Program	Cohort	Source
Entrepreneur First	2022	EF Page

Which accelerators did EndoGene.Bio go through?

EndoGene.Bio is listed by Entrepreneur First (2022).

Where is EndoGene.Bio based?

EndoGene.Bio lists Paris as its location on Entrepreneur First's page.